EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
EyePoint Inc EYPT
$11.70
▼ -5.26%
($-0.65)
Open
$12.35
Prev Close
$12.35
Day Range
$11.68 – $12.50
52W Range
$5.35 – $19.11
Market Cap
$980.94M
Beta
1.69
EPS (TTM)
$-3.50
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2005-01-27 |
| Shares Out. | 83,430,000 |
| Website | eyepoint.bio/ ↗ |
| Phone | 13026365400 |
EyePoint Inc is a publicly traded company under the ticker symbol EYPT on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
18 analysts (2026-05-01)
📰 Latest News for EYPT
Eyepoint announces third consecutive positive DSMC recommendation for phase 3 wet AMD trials for Duravyu(TM), building confidence ahead of mid-2026 topline data
EyePoint Announces Third Consecutive Positive DSMC Recommendation for Phase 3 Wet AMD Trials for DURAVYU™, Building Confidence Ahead of Mid-2026 Topline Data
EyePoint: DURAVYU's Durability Could Drive Significant Upside
EyePoint (EYPT) Q1 2026 Earnings Transcript
RBC Capital Maintains Outperform on EyePoint, Lowers Price Target to $37
EyePoint Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary
Ocular: SOL-1 Success Is Real, But Adoption Risks Keep Me At Hold